Literature DB >> 24675583

Higher intraocular pressure is associated with leukoaraiosis among middle-aged and elderly Koreans without glaucoma or dementia.

B-J Park1, J-K Kim2, Y-J Lee3.   

Abstract

AIM: Leukoaraiosis and high intraocular pressure are strongly associated with cardiovascular disease, vascular angiopathy, and geriatric syndrome. Until now, little is known about the relationship between intraocular pressure and leukoaraiosis in its preclinical stage. The aim of this study was to evaluate the association between intraocular pressure and leukoaraiosis among middle-aged and elderly Koreans without glaucoma or dementia.
METHODS: We examined the relationship of intraocular pressure with leukoaraiosis at a preclinical stage in 753 Korean adults (474 men, 279 women; mean age 57.8 ± 6.6 years). A multiple logistic regression analysis was performed in order to determine whether intraocular pressure is an independent determinant for leukoaraiosis.
RESULTS: The overall prevalence of leukoaraiosis was 7.3%. Mean ocular pressure (±SD) was significantly higher in the leukoaraiosis group than the control group (14.3 ± 2.9 and 13.5 ± 2.9, respectively; P=0.028). In multiple logistic regression analysis, the odds ratio for leukoaraiosis was 1.18 (95% confidence interval: 1.06-1.31) for each 1 mm Hg increase in intraocular pressure.
CONCLUSION: Intraocular pressure was found to be independently and positively associated with leukoaraiosis. This finding indicates that higher intraocular pressure may be a useful additional measure in assessing the risk of leukoaraiosis in the clinical setting.

Entities:  

Mesh:

Year:  2014        PMID: 24675583      PMCID: PMC4058625          DOI: 10.1038/eye.2014.63

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  26 in total

Review 1.  Intraocular pressure: new perspectives.

Authors:  Y Shiose
Journal:  Surv Ophthalmol       Date:  1990 May-Jun       Impact factor: 6.048

Review 2.  A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma.

Authors:  Mona Pache; Josef Flammer
Journal:  Surv Ophthalmol       Date:  2006 May-Jun       Impact factor: 6.048

3.  Elevated intraocular pressure is associated with insulin resistance and metabolic syndrome.

Authors:  Sang Woo Oh; Sangyeoup Lee; Cheolyoung Park; Dong Jun Kim
Journal:  Diabetes Metab Res Rev       Date:  2005 Sep-Oct       Impact factor: 4.876

4.  Platelet aggregation and glaucoma.

Authors:  P F Hoyng; E L Greve; K Frederikse; C Geijssen; H Oosting
Journal:  Doc Ophthalmol       Date:  1985-11-15       Impact factor: 2.379

Review 5.  Pathogenesis of leukoaraiosis: a review.

Authors:  L Pantoni; J H Garcia
Journal:  Stroke       Date:  1997-03       Impact factor: 7.914

6.  Associations with intraocular pressure in the Barbados Eye Study.

Authors:  S Y Wu; M C Leske
Journal:  Arch Ophthalmol       Date:  1997-12

7.  Significant association between leukoaraiosis and metabolic syndrome in healthy subjects.

Authors:  K Park; N Yasuda; S Toyonaga; S M Yamada; H Nakabayashi; M Nakasato; T Nakagomi; E Tsubosaki; K Shimizu
Journal:  Neurology       Date:  2007-05-30       Impact factor: 9.910

8.  Risk factors for open-angle glaucoma. The Barbados Eye Study.

Authors:  M C Leske; A M Connell; S Y Wu; L G Hyman; A P Schachat
Journal:  Arch Ophthalmol       Date:  1995-07

Review 9.  Glaucoma: the damage caused by pressure. XLVI Edward Jackson memorial lecture.

Authors:  D R Anderson
Journal:  Am J Ophthalmol       Date:  1989-11-15       Impact factor: 5.258

10.  A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.

Authors:  A Brun; E Englund
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

View more
  1 in total

1.  Primary Open Angle Glaucoma is Associated with MR Biomarkers of Cerebral Small Vessel Disease.

Authors:  Karl Mercieca; John Cain; Thomas Hansen; Laura Steeples; Amy Watkins; Fiona Spencer; Alan Jackson
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.